Safety, Reactogenicity and Immunogenicity of Vi-DT;Typhoid Conjugate Vaccine
Clinical trial NCT03527355 · COMPLETED
Trial details
- NCT number
- NCT03527355
- Sponsor
- International Vaccine Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-18
- Primary completion
- 2018-07-28
- Enrollment
- 285
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.